Decitabine Plus Arsenic Trioxide for Elderly High-Risk Myelodysplastic Neoplasm
The following is a summary of “Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk myelodysplastic neoplasm patients: a retrospective study,” published in the April 2025 issue of Hem ...